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Summary
 
A simian homologue of Kaposi’s sarcoma–associated herpesvirus (KSHV), the eighth human
herpesvirus (HHV8), was isolated from a simian immunodeficiency virus (SIV)-infected rhesus
macaque (
 
Macaca mulatta)
 
 that developed a multicentric lymphoproliferative disorder (LPD).
This simian rhadinovirus is genetically similar to a recently described rhesus rhadinovirus
(RRV) (Desrosiers, R.C., V.G. Sasseville, S.C. Czajak, X. Zhang, K.G. Mansfield, A. Kaur,
R.P. Johnson, A.A. Lackner, and J.U. Jung. 1997. 
 
J. Virol.
 
 71:9764–9769) and is designated
RRV 17577. RRV 17577 was experimentally inoculated into rhesus macaques with and with-
out SIV
 
mac239
 
 infection to determine if RRV played a role in development of the LPD ob-
served in the index case. In contrast to control animals inoculated with SIV
 
mac239
 
 or RRV
alone, two animals coinfected with SIV
 
mac239 
 
and RRV 17577 developed hyperplastic LPD re-
sembling the multicentric plasma cell variant of Castleman’s disease, characterized by persistent
angiofollicular lymphadenopathy, hepatomegaly, splenomegaly, and hypergammaglobulinemia.
Hypergammaglobulinemia was associated with severe immune-mediated hemolytic anemia in
one RRV/SIV-infected macaque. Both RRV/SIV-infected macaques exhibited persistent
RRV viremia with little or no RRV-specific antibody response. The macaques inoculated
with RRV alone displayed transient viremia followed by a vigorous anti-RRV antibody re-
sponse and lacked evidence of LPD in peripheral blood and lymph nodes. Infectious RRV and
RRV DNA were present in hyperplastic lymphoid tissues of the RRV/SIV-infected
macaques, suggesting that lymphoid hyperplasia is associated with the high levels of replication.
Thus, experimental RRV 17577 infection of SIV-infected rhesus macaques induces some of
the hyperplastic B cell LPDs manifested in AIDS patients coinfected with KSHV.
Key words: B cell hyperplasia • simian immunodeﬁciency virus • rhesus rhadinovirus • 
lymphoproliferative disorders • nonhuman primate 
 
P
 
atients infected with HIV are at an increased risk for
developing opportunistic infections and tumors, partic-
ularly Kaposi’s sarcoma (KS)
 
1
 
 and lymphoproliferative dis-
orders (LPDs). Based on the epidemiology of KS among
HIV patients, it was suggested that an infectious agent
other than HIV must be involved in its pathogenesis (1).
Recently, Chang et al. (2) isolated two short DNA frag-
ments from a novel human herpesvirus that was present in
DNA samples derived from KS lesions from patients with
AIDS using representational differential analysis. This novel
human rhadinovirus is referred to as KS-associated herpes-
virus (KSHV), or human herpesvirus 8 (HHV8), and has
been shown to be present in more than 90% of all KS le-
sions derived from both AIDS and non-AIDS patients (2–10).
In addition to KS, KSHV infection has also been associated
with primary effusion lymphoma (PEL) and multicentric
 
1
 
Abbreviations used in this paper:
 
 BM, bone marrow; CPE, cytopathic ef-
fects; EBV, Epstein-Barr virus; HVS, 
 
Herpesvirus saimiri
 
;
 
 
 
KS, Kaposi’s sar-
coma; KSHV, KS-associated herpesvirus; LMP, latent membrane protein;
LPDs, lymphoproliferative disorders; MCD, multicentric Castleman’s dis-
ease; MIP, macrophage inflammatory protein; orfs, open reading frames;
PEL, primary effusion lymphoma; RRV, rhesus rhadinovirus; SIV, sim-
ian immunodeficiency virus; TS, thymidylate synthase. 
828
 
B Cell Hyperplasia in Rhesus Monkeys
 
Castleman’s disease (MCD) in AIDS patients. Both are
unique B cell proliferative disorders that often occur in pa-
tients with AIDS-related KS (11–14).
Despite the accumulation of both molecular and sero-
logical data supporting the role of KSHV in KS, PEL, and
MCD, understanding how KSHV is involved in these dis-
eases is complicated by the absence of a relevant animal
model. Attempts to induce KS or LPD by experimental
KSHV infection of nonhuman primates previously infected
with the simian immunodeficiency virus (SIV) have been
unsuccessful, suggesting that KSHV, like human CMV,
displays a strict species specificity (15). Although related
gammaherpesviruses, namely 
 
Herpesvirus saimiri
 
 (HVS) and
murine herpesvirus type 68, can cause LPD in some exper-
imentally infected animals, they are inadequate models for
KSHV pathogenesis, as they lack the KSHV-unique genes
encoding the viral (v)IL-6 homologue, viral macrophage
inflammatory proteins (vMIP-1), vIFN regulatory factor,
and other rhadinovirus-unique genes that may contribute
to pathogenesis (16, 17).
Recently, it was reported that rhesus macaques naturally
harbor a rhadinovirus related to KSHV (18). Preliminary
characterization of a 10.6–kilobase pair (kb) segment of the
rhesus rhadinovirus (RRV) genome revealed a genetic or-
ganization similar to KSHV that included an IL-6–like
gene in a position analogous to the IL-6–like gene encoded
by KSHV. Despite the high incidence of RRV infection in
captive rhesus macaques, no diseases have clearly been asso-
ciated with RRV infection. However, analogous to hu-
mans infected with HIV and KSHV, animals infected with
SIV or simian type D retrovirus (SRV) exhibit an increased
frequency of LPD- and KS-like mesenchymoproliferative
disorders than do immunocompetent animals, suggesting a
role for infectious agents other than these immunosuppres-
sive retroviruses (19–22). Recently, DNA sequences re-
sembling those of KSHV were found in retroperitoneal fi-
bromatosis tissue, a spindle cell tumor that is histologically
similar to KS in SRV-infected macaques (23). Here we re-
port the isolation of RRV strain 17577 from an SIV-
infected rhesus macaque that developed a persistent multi-
centric LPD. SIV-infected rhesus macaques experimentally
coinfected with RRV 17577 developed a hyperplastic B
lymphocytic LPD resembling MCD, indicating that exper-
imental RRV 17577 infection of SIV-infected rhesus
macaques is a good model for the study of KSHV-associ-
ated B lymphocyte LPD manifested in AIDS patients.
 
Materials and Methods
 
Virus Isolation and Electron Microscopy.
 
A bone marrow (BM)
aspirate was collected in preservative-free ammonium heparin
(1,000 U/ml) from a 2 y, 202-d-old captive-reared rhesus
macaque 1 mo after experimental inoculation with a macrophage-
tropic variant of SIV
 
mac239
 
. The BM aspirate was dispersed, and
isopynic gradient-purified (Ficoll-Paque; Pharmacia) BM mono-
nuclear cells were seeded into T-25 culture flasks and grown in
the presence of endothelial serum-free media (GIBCO BRL)
supplemented with 10% fetal bovine serum, 1% 
 
l
 
-glutamine, 1%
penicillin/streptomycin/neomycin, and 30 
 
m
 
g/ml endothelial
cell growth supplement (GIBCO BRL). Primary BM mononu-
clear cell cultures developed cytopathic effects (CPE) after 10–12 d
and were rapidly frozen in liquid N
 
2
 
 and thawed, and then super-
natants were clarified by centrifugation and filtered through a
0.45-
 
m
 
M membrane. The filtered BM mononuclear cell culture
extracts were inoculated on primary rhesus monkey fibroblast
cultures (24). Fibroblast cultures developing CPE were scraped
free into medium, pelleted at 400 
 
g
 
, washed in PBS, and sus-
pended in cold Ito and Karnovsky’s fixative (2.5% glutaralde-
hyde, 0.5% picric acid, 1.6% paraformaldehyde, 0.005% ruthe-
nium red) in 0.1 M sodium cacodylate buffer, pH 7.4, for 2 h. Ito
and Karnovsky’s–fixed cells were washed in cacodylate buffer,
postfixed in 1% OsO
 
4
 
 and 0.8% K
 
3
 
Fe (Cn)
 
6
 
 in cacodylate buffer
for 1 h, rinsed in distilled H
 
2
 
O, and prestained in 2% aqueous
uranyl acetate for 1 h. Fixed and prestained cells were dehydrated
in a graded series of acetone, embedded in Epon 812 epoxy resin,
polymerized at 60
 
8
 
C, and sectioned at 60 nm on an MT 5000 ul-
tramicrotome. Copper grid–mounted sections were stained with
lead citrate and uranyl acetate and viewed on a Phillips 300 elec-
tron microscope.
 
Virus Purification and Isolation of vDNA.
 
Cell-free virus iso-
lated from the primary BM mononuclear cell culture was serially
passaged three times in primary rhesus fibroblasts to generate viral
stocks, and the stocks were titered on primary rhesus fibroblasts
before animal infection studies. For the isolation of vDNA, in-
fected primary rhesus fibroblasts from two 850 cm
 
2
 
 roller bottles
were harvested and the cell debris removed by low speed centrif-
ugation. The cell pellet was resuspended in culture medium, son-
icated to release intracellular virus particles, and centrifuged to
pellet cell debris. Virus was pelleted from supernatants by high
speed centrifugation in a Beckman JA-14 rotor (Beckman Instru-
ments, Inc.) for 1 h at 9,000 rpm and purified through a six-step
sorbitol gradient ranging from 20 to 70% spun in a Beckman
SW41 rotor for 2 h at 18,000 rpm. Gradient-purified virus was
diluted in balanced buffered salts solution and pelleted through a
20% sorbitol cushion. The virus pellet was resuspended in Tris/
EDTA buffer (TE; 10 mM Tris/HCl, pH 8.0, and 1 mM EDTA)
and lysed in TE with 0.6% SDS and proteinase K (2 mg) at 37
 
8
 
C
for 5 h. vDNA was isolated by CsCl
 
2
 
 gradient centrifugation in a
Beckman Ti 75 rotor at 38.4 
 
3 
 
10
 
3 
 
rpm for 72 h, collected, and
dialyzed against TE.
 
PCR Amplification of the Herpesvirus Polymerase Gene.
 
PCR am-
plification of the herpesvirus polymerase gene was performed on
purified vDNA using the following degenerated herpesvirus (HV)
primers: HV-5, 5
 
9
 
-GCTCTAGATT(C,T)GA(C,T)AT(A,C,T)GA
(A,G)TG(CT)-3
 
9
 
; and HV-6, 5
 
9
 
-GGATTCGG(G,A)AA(C,T)
TC(G,A)TA(A,C,G,T)AC(A,C,G,T)TC-3
 
9
 
. The conditions for
PCR amplification were as follows: 94
 
8
 
C for 2 min (1 cycle);
94
 
8
 
C for 1 min, 37
 
8
 
C for 1.5 min, 3-min ramp to 72
 
8
 
C, 72
 
8
 
C for
1.5 min (10 cycles); 94
 
8
 
C for 1 min, 50
 
8
 
C for 1 min, 72
 
8
 
C for
1.25 min (30 cycles); and 72
 
8
 
C extension for 10 min (1 cycle).
Each PCR reaction used 0.1 
 
m
 
g of DNA, 50 pmol of each
primer, 1 U of Vent polymerase, 40 
 
m
 
M of each deoxynucle-
otide triphosphate, 10 mM KCl, 10 mM Tris/HCl, pH 8.8, 10
mM (NH
 
4
 
)
 
2
 
SO
 
4
 
, and 0.1% Triton X-100 in a final volume of 50
 
m
 
l. Amplification was performed in a Perkin-Elmer 2400 Ther-
mocycler. PCR products were run out on a 1% agarose gel; DNA
fragments were isolated and restriction endonuclease digested
with XbaI and EcoRI for cloning into pSP73 (Promega Corp.).
Included in the degenerate PCR assay were DNA samples from
rhesus CMV- and rhesus Epstein-Barr virus (EBV)-like lympho-
cryptovirus–infected cells (24, 25). DNA sequencing was performed 
829
 
Wong et al.
with Applied Biosystems (ABI) PRISM Dye Terminator Cycle Se-
quencing Ready Reaction Kits with AmpliTaq DNA polymerase
as per the manufacturer’s instructions. The DNA sequence was
then determined on an ABI 373A sequencer in the Molecular Bi-
ology Core at the Oregon Regional Primate Research Center
(ORPRC, Beaverton, OR). All plasmids were sequenced in both
directions to verify DNA sequences. Open reading frames (orfs)
were identified with MacVector (version 5.0; Oxford Molecular
Group), and amino acid sequences were aligned by the CLUSTAL
method (26) used with the MEGALIGN program provided with
DNASTAR biocomputing software for the Macintosh. 
 
Cloning and DNA Sequence Analysis of a Fragment Hybridizing
to the KSHV Thymidylate Synthase Gene.
 
Viral genomic DNA
(5 
 
m
 
g) was restriction endonuclease digested with EcoRI, run out
on a 1% agarose gel, and transferred to nitrocellulose. For use as a
probe, the KSHV thymidylate synthase (TS) gene was generated
by PCR amplification from DNA isolated from BCBL-1 cells
(27) with oligonucleotide primers corresponding to a specific re-
gion of the KSHV genome encoding TS (nucleotides 20,236–
20,650) (28) using standard PCR conditions. Immobilized
vDNA was probed with random-primed, [
 
32
 
P]dCTP-labeled
KSHV TS for 16 h at 42
 
8
 
C. Hybridized membranes were then
washed using conditions of moderate stringency (0.2
 
3
 
 SSC and
0.1% SDS at 50
 
8
 
C) for 1 h, and bound probe was visualized by
exposing DuPont-NEN reflection film to the washed membrane
at 
 
2
 
80
 
8
 
C with a DuPont-NEN reflection screen. The corre-
sponding vDNA fragment found to hybridize was isolated and
further digested with restriction endonuclease BamHI, which
yielded a 3.4-kb fragment that was found to hybridize to the
KSHV TS probe. This fragment was cloned into pSP73 and sub-
jected to DNA sequence analysis as described above. Orfs were
identified using MacVector software for the Macintosh, and the orfs
were compared with SwissProt and PIR protein databases for ho-
mologous orfs with BLASTX. Alignments to identified proteins
were generated either by the GAP program from the Wisconsin
GCG analysis package (version 9.1; Oxford Molecular Group) or
by the CLUSTAL program provided with the DNASTAR pro-
gram. Sequences for RRV 17577 IL-6, TS, and MIP are available
from EMBL/GenBank/DDBJ under accession number AF087411.
 
PCR Amplification for Detection of RRV DNA in Animal Sam-
ples.
 
DNA extractions from peripheral blood and tissues were
performed with a Puregene DNA isolation kit essentially as
described by the manufacturer (Gentra Systems). PCR amplifica-
tion for detecting the presence of the RRV genome was per-
formed with the following oligonucleotide primers: vMIP-1,
5
 
9
 
-CCTATGGGCTCCATGAGC-3
 
9
 
; and vMIP-2, 5
 
9
 
-ATC-
GTCAATCAGGCTGCG-3
 
9
 
. PCR amplification for detecting
the rhesus EBV genome was accomplished with oligonucleotide
primers derived from published sequences of the latent mem-
brane protein (LMP)-1 (29). PCR amplification of the rhesus
 
b
 
-globin gene was used as a control for the amount and quality of
DNA used for each reaction (30). With the exception of
 
b
 
-globin, the conditions for PCR were 94
 
8
 
C for 2 min (1 cycle);
94
 
8
 
C for 0.5 min, 50
 
8
 
C for 0.5 min, 72
 
8
 
C for 0.5 min (30 cycles);
and 72
 
8
 
C extension for 5 min (1 cycle). For the rhesus 
 
b
 
-globin
PCR, the annealing temperature was raised to 55
 
8
 
C. Each PCR
reaction used 0.1 
 
m
 
g of total DNA, 50 pmol of each primer, 1 U
of Vent polymerase, 40 
 
m
 
M of each deoxynucleotide triphos-
phate, 10 mM KCl, 10 mM Tris/HCl, pH 8.8, 10 mM
(NH
 
4
 
)
 
2
 
SO
 
4
 
, 2 mM MgSO
 
4
 
, and 0.1% Triton X-100 in a final
volume of 50 
 
m
 
l. The PCR reactions were run out on a 1% aga-
rose gel, transferred to nitrocellulose, and probed with a
[
 
32
 
P]ATP-labeled oligonucleotide primer specific for vMIP
(vMIP-3, 5
 
9
 
-ATATTAAACACTCGCCGC-3
 
9
 
), rhesus EBV
LMP-1, or 
 
b
 
-globin. Hybridizations were performed overnight
at room temperature in 6
 
3
 
 SSC, 0.1% SDS, and 10 mg/mL
 
Escherichia coli
 
 tRNA. Southern blots were then washed with 2
 
3
 
SSC and 0.1% SDS twice at room temperature, followed by two
washes for 1 h in 2
 
3
 
 SSC and 0.1% SDS at 47
 
8
 
C (vMIP), 45
 
8
 
C
(
 
b
 
-globin), or 52
 
8
 
C (rhesus EBV LMP-1), and bound probe was
visualized by exposing DuPont-NEN reflection film to the
washed membrane at 
 
2
 
80
 
8
 
C.
 
Antibody Testing for RRV Infection.
 
RRV 17577–infected cells
were solubilized with 0.5% NP-40 and 1% sodium deoxycholate
in PBS and clarified in a Beckman SW28 rotor at 23,500 rpm for
1 h at 4
 
8
 
C. The clarified supernatant was used as antigen for coat-
ing 96-well Maxisorp plates (500 ng/well; Nunc, Inc.). ELISAs
were then performed essentially as described (31).
 
Experimental Infection and Evaluation of Animals.
 
All aspects of
the animal studies were performed according to institutional
guidelines for animal care and use at the ORPRC. Rhesus mon-
keys (identification numbers 18483, 18503, 18540, and 18570)
were inoculated intravenously with cell-free supernatants con-
taining the equivalent of 5 ng of SIV
 
mac
 
 p27 prepared from Cos-1
cells transfected with a full length SIV
 
mac239
 
 molecular clone (32).
Before experimental SIV inoculation, PBMCs from the four
monkeys were prescreened for in vitro susceptibility to SIV
 
mac239
 
infection essentially as described (33). 8 wk after SIV infection,
animals 18483 and 18570 were inoculated intravenously with 5 
 
3
 
10
 
6
 
 PFU of RRV 17577. Two additional animals, 19092 and
19286, were also inoculated with 5 
 
3
 
 10
 
6
 
 PFU of RRV 17577 as
RRV-only controls. At sequential time points, animals were se-
dated with ketamine hydrochloride (10 mg/kg body weight) and
given complete physical examinations. Venipunctures were per-
formed, and EDTA- or preservative-free ammonium heparin–
anticoagulated blood samples were collected and separated into
plasma and PBMCs for analysis. Serial peripheral LN biopsies
were performed, and PBMCs and dispersed LN mononuclear
cells were cultured in 1640 medium (GIBCO BRL) supple-
mented with 20% fetal bovine serum, 1% 
 
l
 
-glutamine, and 1%
penicillin/streptomycin/neomycin to determine if continuously
replicating or transformed cells were present. Plasma was moni-
tored for SIV p27 during the first 4 wk after infection using the
SIV p27 antigen capture ELISA (Coulter Immunology). Dupli-
cate plating of 2 
 
3
 
 10
 
5
 
 PBMCs or LN mononuclear cells on pri-
mary rhesus fibroblasts and PCR analysis of PBMCs and LN
mononuclear cell DNA was used for RRV isolation and the de-
tection of RRV DNA, respectively. Animals that became mori-
bund were killed, and complete necropsies were performed. Tis-
sues were snap-frozen in liquid N
 
2
 
 for PCR analysis or fixed in
neutral-buffered formalin, embedded in paraffin, sectioned, and
stained with hematoxylin and eosin for light microscopy. Fresh
PBMCs and dispersed mononuclear cells from lymphoid tissues
were collected for leukocyte subset analyses, primary culture, and
virus isolation via cocultivation with primary rhesus fibroblasts or
cryopreserved for PCR analysis.
Alterations in subsets were monitored sequentially after exper-
imental inoculations by FACS™ analysis (Becton Dickinson). T
lymphocyte subsets were labeled with OKT4 (CD4; Ortho Diag-
nostic Systems, Inc.) and B9.11 (CD8, Coulter Immunology)
mAbs. B lymphocytes were labeled with B-Ly-1 (CD20; Coulter
Immunology) mAb. The CD23 and CD40 B cell activation
markers were identified with EBVCS4 (provided by Dr. B. Sug-
den, University of Wisconsin, Madison, WI) and G28-5 (pro-
vided by Dr. J. Ledbetter, XCYTE Therapies, Seattle, WA)
mAbs, respectively (34, 35). Total serum Ig (IgG and IgM) con-830 B Cell Hyperplasia in Rhesus Monkeys
centrations and k and l light ratios in total serum Ig were deter-
mined by nephelometry, and the Coombs’ test (direct antiglobu-
lin) was performed to determine if hemolytic anemia in one of
the animals was immune mediated (Quest Diagnostics, Inc.).
Results
Isolation and Characterization of RRV Strain 17577. Primary
cell cultures established with BM mononuclear cells from
macaque 17577 developed CPE in the fibroblast-like ad-
herent cells after 10–12 d in culture and were harvested for
passage. Primary rhesus monkey fibroblast cultures were in-
oculated with filtered extracts from the primary BM cul-
tures. 10–12 d after inoculation, fibroblast cultures devel-
oped CPE characterized by granular focal lesions followed
by cell rounding and sloughing that generated holes in the
monolayer (Fig. 1 a). Transmission electron microscopic
examination of the infected fibroblasts revealed 150–200-nm
virus particles with characteristic dense cores resembling
herpesviruses in the extracellular spaces as well as immature
and mature virus particles in the nuclei and cytoplasm, re-
spectively (Fig. 1 b). This herpesvirus isolate was subse-
quently passaged, purified, and titered on primary rhesus fi-
broblasts, and vDNA was purified from cell-free virions for
molecular characterization.
The initial molecular characterization of the virus was
conducted using degenerate PCR analysis targeting a con-
served region of the vDNA polymerase gene (FDIEC-
VYEFP) from beta- and gammaherpesviruses. Purified
vDNA, which was capable of producing infectious virus
from CaCl2-transfected fibroblasts, was subjected to PCR,
and the resulting fragments were cloned and sequenced. As
controls, we included DNA from rhesus CMV– and rhesus
EBV–infected cells as well as DNA from uninfected cells.
This comparative analysis revealed that the virus was a
gammaherpesvirus, as the deduced amino acid sequence
was more closely related to rhesus EBV than rhesus CMV
(Table I). Inclusion of amino acid sequences from other
known gammaherpesviruses, such as KSHV and HVS, sup-
ported this assignment. Moreover, comparative analysis
with the recently described RRV strain H26-95 revealed
that the herpesvirus isolate recovered from rhesus macaque
17577 was an RRV.
To further characterize RRV strain 17577, we screened
vDNA, restriction endonuclease digested with EcoRI, by
Southern blot analysis for the presence of a TS gene, an un-
spliced cellular gene homologue that is conserved in KSHV
and HVS but not EBV. Using a KSHV TS gene fragment
as a probe, a single DNA fragment was found to hybridize
under conditions of moderate stringency (data not shown).
This DNA fragment was subsequently isolated and further
digested for subcloning and DNA sequence determination.
DNA sequence analysis of a 3.4-kb fragment revealed
three orfs, two with striking homology to KSHV and a sin-
gle orf having 100% identity with RRV and limited ho-
mology to cellular IL-6 (Table I). One orf encodes a
homologue of KSHV MIP-II with 30.9% amino acid se-
quence identity, as defined by the GAP program provided
with the Wisconsin GCG analysis package, and the second
Figure 1. Productive infection of primary rhesus fibroblasts with her-
pesvirus. (a) Early stage CPE (magnification 100). (b) Electron micrograph
of monolayers exhibiting CPE reveals immature herpesvirus particles in the
nucleus and mature enveloped viral particles in the extracellular space.
Table I. Amino Acid Sequence Identity of RRV Strain 17577 
Orfs with Orfs from Selected Herpesviruses or Human or Rhesus 
Macaque Cellular Homologues
Orf
Selected primate herpesviruses
Cellular
homologues
KSHV HVS RhEBV RhCMV RRV Human Rhesus
Pol 50.8 50.8 55.0 40.0 100 ND NA
IL-6 12.7 NA NA NA 100 17.8 17.8
TS 66.1 64.6 NA NA NA ND NA
MIP 32.3 NA NA NA NA 26.1 NA
(MIP-II) (MIP-1b)
Amino acid sequences were aligned by GAP or CLUSTAL and the
percent identity determined. Rh, rhesus; Pol, DNA polymerase; NA,
not available.831 Wong et al.
Figure 2. Multicentric lymphoproliferative disease in SIVmac-infected rhesus macaque 17577. (a) Axillary LN with prominent, poorly defined, hyper-
plastic germinal centers (GC), rarified mantle zone (M), plasma cell infiltration in an accentuated interfollicular sinus (S), and stromovascular changes in
the interfollicular zone and germinal center (arrows); bar, 40 mm. (b) Inset outlined in panel a illustrating marked plasmacytosis; bar, 20 mm. (c) Marked
follicular lymphoid hyperplasia in BM with mitotic cells indicated by arrows. Multiple pleomorphic lymphoid nodules were present in lung (d), kidney
(e), and brain (f).832 B Cell Hyperplasia in Rhesus Monkeys
orf encodes a homologue of both cellular and vTS, with 66
and 64.6% amino acid sequence identity with KSHV and
HVS, respectively. The third orf revealed 100% identity
with RRV strain H20-95 IL-6, supporting our initial find-
ing that the 17577 virus is an RRV.
RRV Is Present in Tissue Harboring LPD. Rhesus macaque
17577 was humanely killed 503 d after SIV infection and
found to have multicentric LPD involving both lymphoid
and nonlymphoid tissues. Attempts to propagate continu-
ously replicating or transformed cells from mononuclear
cells dispersed from BM and LNs were unsuccessful. Histo-
pathologically, there was marked follicular lymphoid hy-
perplasia in LNs, spleen, and BM. The follicular elements
were dominated by giant, often irregularly shaped, second-
ary, reactive germinal centers. Follicular architecture in the
cortices of LNs was accentuated by expanded cellular inter-
follicular zones dominated by plasma cells and vascular and
stromal elements (Fig. 2, a and b). The medullary cords
were densely populated by plasma cells, and arborizing
cords of plasma cells extended into the paracortical zones.
Follicular lymphoid hyperplasia was particularly striking in
the BM (Fig. 2 c). The LPD lesions in nonlymphoid tissues
were principally nodular, pleomorphic lymphoid masses
composed of cytologically normal lymphocytes, plasma
cells, and macrophage-like cells that effaced normal tissue
architecture (Fig. 2, d and e).
To determine if the LPD lesions in macaque 17577 har-
bored RRV, oligonucleotide primers specific to the RRV
MIP homologue were designed to detect vDNA by PCR
amplification and Southern blot analysis. By semiquantita-
tive PCR analysis, vDNA sequences were found to be
present at .590 copies/0.1 mg of BM-derived DNA (Fig.
3 a). As most animals held in captivity are naturally infected
with RRV (18, 36), BM aspirates were obtained from
other animals to determine if RRV is a common resident
of BM. BM samples were collected from two SIV-infected
animals without peripheral lymphadenopathy, and two ad-
ditional samples were obtained from animals that were
killed due to disease unrelated to SIV infection or LPD.
Analysis of these samples revealed no detectable signal, sug-
gesting that RRV DNA in the BM-derived DNA from
these four animals was either absent or below the limits of
detection (Fig. 3 b). Finally, the BM-derived DNA from
macaque 17577 was analyzed for rhesus EBV–specific se-
quences, as rhesus EBV has been shown to be associated
with LPD in SIV-infected animals (37). No signal corre-
sponding to rhesus EBV DNA sequences was detected
(Fig. 3 c), indicating that rhesus EBV was not present in
this lesion.
Experimental Inoculation of Macaques with RRV Strain
17577. To test whether RRV strain 17577 can cause dis-
ease in its natural host, six juvenile rhesus macaques were
selected for experimental inoculation studies. All six ma-
caques were z1.5 yr old and shown to be negative for
RRV infection over a 6-mo period by absence of RRV-
specific serum antibody as measured by whole-virus
ELISA, failure to detect RRV sequences in peripheral
blood leukocytes by PCR analysis, and failure to isolate
RRV from PBMCs cocultured with primary rhesus fibro-
blasts. As .75% of immunocompetent animals in our col-
ony are seropositive for RRV by 3 yr of age and do not
develop spontaneous LPD, we initially inoculated four of
the animals with SIVmac239 to provide a background of im-
munosuppression before experimental RRV inoculation. 8
wk after SIV infection, two of the four animals inoculated
with SIV (18483 and 18570) were inoculated intravenously
with 5 3 106 PFU of cell-free RRV 17577. The two re-
maining SIV-infected animals (18503 and 18540) were
maintained as SIV-only infection controls. Two additional
animals (19092 and 19286) were infected with RRV
17577 to serve as RRV-only infection controls.
Sequential FACS™ analysis of PBMCs from the experi-
mental animals revealed limited CD41 lymphocyte deple-
tion (mean values 5 900–1,100/ml) 2 wk after SIV infec-
tion in the SIV-infected animals, followed by a rebound
and sustained CD41 lymphocyte counts in the normal
range (mean values 5 1,500–2,000/ml), whereas CD81
lymphocyte counts increased slightly compared with the
preinoculation time points. Significant differences in the
number of CD201 B lymphocytes were observed among
the three groups of animals. As early as 6 wk after RRV in-
fection, the number of CD201 B lymphocytes increased
dramatically in the two RRV/SIV-infected macaques
(mean values 5 2,900–3,360/ml) and persisted for 34 wk in
animal 18483 and 14 wk in animal 18570 (Fig. 4, a and b).
In contrast, the SIV-infected control animals exhibited per-
sistently low numbers of CD201 B lymphocytes (mean val-
ues  5  200–300/ml) beginning 2 wk after SIV infection
(Fig. 4, c and d). The number of circulating CD201 B lym-
phocytes increased slightly 2 wk after infection (mean val-
ues 5 950–1,000/ml) in the RRV-only controls (Fig. 4, e
Figure 3. PCR amplification and
hybridization for RRV in BM from
an animal (17577) with LPD. (a)
Semiquantitative PCR of BM-derived
DNA from the SIV-infected animal
with LPD for RRV MIP. Lane 1, BM-derived DNA; lane 2, 100 pg of
DNA from uninfected cells; lane 3, 100 pg of DNA from uninfected cells
plus 100 fg of vDNA; lane 4, 100 pg of DNA from uninfected cells plus 1
pg of vDNA; lane 5, 100 pg of DNA from uninfected cells plus 10 pg of
vDNA; lane 6, 100 pg of DNA from uninfected cells plus 100 pg of
vDNA. (b) PCR and Southern blot analysis of DNA amplified from BM
for RRV MIP or rhesus b-globin gene. The source for each BM sample
is indicated above each lane. The negative (2) control is DNA isolated
from uninfected rhesus fibroblasts. (c) Southern blot analysis of DNA
PCR amplified with oligonucleotide primers specific for the rhesus
(Rh)EBV LMP-1 gene or rhesus b-globin gene. The source for each
sample is indicated above each lane. The negative (2) control is DNA
isolated from uninfected rhesus fibroblasts, and the positive (1) control is
DNA from RhEBV-infected cells.833 Wong et al.
Figure 4. CD201 lymphocytes, antibody response, and RRV strain 17577 isolation/detection in SIVmac-infected animals. Total CD201 cells were
measured at the indicated weeks after infection, virus isolations (virus PBMCs) were determined by coculture of PBMCs with primary rhesus fibroblasts,
and the presence of vDNA (virus PCR) was determined by PCR analysis on DNA derived from PBLs. Detection of antibodies to RRV strain 17577
were determined by ELISA on plates coated with extracts derived from RRV-infected cells. 1, positive for virus culture or vDNA, as defined by PCR
and Southern blot analysis; 2, negative virus culture or vDNA. Animals 18483 (a) and 18570 (b) were experimentally inoculated with SIVmac239 and
RRV strain 17577, animals 18503 (c) and 18540 (d) were experimentally inoculated with SIVmac239 only, and animals 19092 (e) and 19286 (f) were ex-
perimentally inoculated with RRV strain 17577.834 B Cell Hyperplasia in Rhesus Monkeys
and f). Further FACS™ analysis revealed that the PBMCs
from the two RRV/SIV-infected macaques expressed the
CD40 activation marker coincident with CD20 but not
CD23, which is expressed after rhesus EBV infection (ref-
erence 38; data not shown).
RRV was readily recovered from PBMCs of the two
RRV/SIV-infected animals as early as 4 wk after RRV in-
fection in macaque 18570 and 8 wk after infection in
macaque 18483. Subsequently, positive virus cultures were
obtained repeatedly from these animals for the duration of
the study (Fig. 4, a and b). The PBMCs from the two
RRV/SIV-infected animals were also shown to harbor
RRV DNA 4 wk after RRV inoculation in macaque
18483 and 14 wk after infection in macaque 18570, as de-
termined by PCR and Southern blot analysis for the vMIP
gene. Interestingly, no substantial difference in cell-associ-
ated viral load was discernible in PBMCs throughout the
course of infection by PCR or virus isolation (data not
shown). The two SIV-only control macaques were consis-
tently negative for RRV by both methods of detection
(Fig. 4, c and d). The RRV-only control macaques were
positive for RRV by both methods of detection 2 wk after
infection and remained positive through 6 wk after infec-
tion (Fig. 4, e and f).
The humoral response to RRV infection was assessed
sequentially using a whole-virus ELISA. One of the two
RRV/SIV-infected animals failed to develop a measurable
antibody response to RRV, whereas a low antibody re-
sponse to RRV was detected in the second RRV/SIV-
infected macaque 4 wk after RRV infection (Fig. 4, a and
b). Both of the SIV-only controls remained seronegative
for RRV for the duration of the study (Fig. 4, c and d),
whereas the two RRV-only controls developed strong sus-
tained anti-RRV antibody responses beginning 2 wk after
infection (Fig. 4, e and f).
Clinical and Pathological Findings. Early symptoms of
SIV infection included fever, mild skin rash, and malaise,
coincident with primary SIV p27 antigenemia in the four
SIV-infected macaques by 2 wk after SIV infection. 10 wk
after RRV infection, the two RRV/SIV-infected macaques
developed marked peripheral lymphadenopathy, which
persisted for .56 wk in macaque 18483 and 31 wk in
macaque 18570. Additionally, the two RRV/SIV-infected
macaques developed marked, persistent splenomegaly with
spleens z10 times normal size. 30 wk after RRV infection,
macaque 18570 developed severe hemolytic anemia that
was unresponsive to treatment with prednisolone and was
killed 286 d after RRV infection. At necropsy, there was
marked generalized lymphadenopathy, hepatomegaly, sple-
nomegaly, diffuse erythroid hyperplasia in the BM, and mem-
branous glomerulonephritis. Analysis of necropsy tissues for
vDNA indicated that virus was present in all lymphoid or-
gans (Fig. 5). Of particular interest is the absence of vDNA
in the BM, which also did not exhibit lymphoid hyperpla-
sia observed in the BM of macaque 17577 from which
RRV 17577 was isolated. Only slight transient peripheral
LN enlargement was seen in the SIV- and RRV-only con-
trol macaques, and splenomegaly was not observed.
Histopathologic examination of peripheral LN biopsy
samples revealed marked differences between the three
groups. 27 wk after RRV infection, LNs from the two
RRV/SIV-infected macaques had marked angiofollicular
lymphoid hyperplasia characterized by giant, secondary, re-
active germinal centers that were frequently irregular in
shape and lacked distinct mantle zones. Medullary cords
and paracortical areas were infiltrated by sheets of plasma
cells. The interfollicular zones were accentuated and rela-
tively hypocellular, with increased vascularity and plasma
cell infiltration (Fig. 6, a and b). The lymphoid hyperplasia
was persistent and multicentric. Virtually all of the LNs re-
covered from macaque 18570 at necropsy were profoundly
enlarged. The morphologic changes were similar to those
observed in the LN biopsy 27 wk after RRV infection,
with the exception that the necropsy LN samples contained
a mix of both secondary reactive and tertiary regressive ger-
minal centers, with vascular hyalinization in most LNs.
Plasma cells dominated the medullary cords, paracortex,
and interfollicular zones. The spleen of macaque 18570 also
contained large, irregularly shaped lymphoid follicles that
lacked mantles and were composed of a mosaic pattern of
hyalinized cell-poor areas and cellular areas of normally
proliferating germinal center lymphocytes. Cords and is-
lands of mature plasma cells were prevalent in the red pulp
(data not shown). In contrast, LNs from the control SIV
animals, collected 35 wk after SIV infection, had pro-
foundly atrophied lymphoid follicles and hypocellular para-
cortices with condensed stromal elements characteristic of
SIV-induced lymphoid atrophy (Fig. 6 c; reference 39). LN
biopsies from the two RRV control macaques 9 wk after
infection had normal histologic features (Fig. 6 d).
Immunophenotyping of LN mononuclear cells revealed
significant differences in the number of CD201 B lym-
Figure 5. PCR analysis of PBLs and tissues from animal
18570 collected at necropsy for RRV DNA and rhesus
b-globin. Mes, mesenteric; Axil, axillary; ves, vesicle; In-
guin, inguinal; parotid, parotid gland.835 Wong et al.
phocytes in the LNs from the two RRV/SIV-infected
macaques compared with LNs from macaques in the SIV-
and RRV-only control groups. The four animals in the
two control groups had twofold increases in the number of
LN CD201 B lymphocytes compared with preinoculation
samples, whereas the two RRV/SIV-infected animals had
fourfold increases in the number of CD201 B lymphocytes
compared with the preinoculation control samples and
twofold increases over the postinfection samples from the
two control groups (Fig. 7). Attempts to culture continu-
ously replicating or transformed cells from dispersed LN
mononuclear cells and PBMCs were unsuccessful.
Coinfection with SIV and RRV resulted in a marked in-
crease in serum IgG (Table II). Two RRV/SIV experi-
mentally infected macaques, as well as macaque 17577
from which RRV strain 17577 was recovered, developed
marked hypergammaglobulinemia (serum IgG . 2,000
mg/dl). k and l Light chain levels in total plasma Ig in-
creased from mean preinfection values of 96 and 121 mg/dl
in 17577 and the two RRV/SIV experimentally infected
macaques to 149 and 212 mg/dl, respectively. The pre-
and postinfection mean k and l light chain ratios were 0.8
and 0.7, respectively, indicating that the increase in plasma
light chain concentrations was not associated with appre-
ciable skewing. Postinfection total plasma Ig k and l levels
decreased in the single SIV-only animal tested (18503), also
without appreciable skewing. Terminal serum from
macaque 18570 was also positive in the direct antiglobulin
(Coombs’) test, strongly suggesting that the hemolytic ane-
mia in this animal was immune mediated. Modestly ele-
vated serum IgG (1,233 mg/dl) was noted in SIV-only
control macaque 18540. Increases in serum IgG were not
observed in the second SIV-only control macaque or the
two RRV-only control macaques (serum IgG ,700 mg/dl).
Figure 6. Axillary LNs from RRV/SIV-, SIV-, and RRV-infected animals. (a) Angiofollicular lymphoid hyperplasia in SIVmac- and RRV-infected
macaque 18570 with prominent germinal center (GC) and cellular interfollicular sinus (S) and paracortex (P). (b) Higher magnification of boxed area in
panel a, with numerous interfollicular plasma cells (arrows), increased vascular stroma with hypertrophied endothelial cells (arrow heads), and effaced
mantle zone (M). (c) Marked lymphoid atrophy in SIVmac-only control macaque 18503. The cortex is thin and sinuses (S) are dilated. Involuted, hyalin-
ized germinal centers (GC) are difficult to visualize, and the paracortex (P) consists of condensed stroma and sparse small lymphocytes. (d) Normal follic-
ular architecture in RRV-only control macaque 19286. Hematoxylin and Lee stain; bars: a, 50 mm; b, 25 mm; c, 50 mm; and d, 50 mm.836 B Cell Hyperplasia in Rhesus Monkeys
Normal polyclonal electrophoretic profiles were obtained
from all serum samples (data not shown).
Discussion
In this study, we describe the isolation of RRV strain
17577 from an SIV-infected rhesus macaque that eventu-
ally developed LPD. Like the RRV isolate previously de-
scribed by Desrosiers et al. (18), strain H26-95, the isolate
described here encodes a vIL-6–like cytokine gene. More-
over, this isolate also contains a vMIP-like homologue with
amino acid sequence identity to KSHV vMIP-II. Sequence
analysis of the entire RRV strain 17577 genome has re-
cently been completed and reveals that the genome is es-
sentially colinear with KSHV and possesses similar genes
with the potential for transformation, regulation of apopto-
sis, or growth control as KSHV (40). In particular, RRV
possesses a gene, referred to as R1, in the same position as
saimiri transforming protein and K1 of HVS and KSHV,
respectively. BLAST analysis with R1 shows that the NH2
terminus is similar to that of the Fc receptor, suggesting
that R1 is a transmembrane receptor and therefore may be
involved in signal transduction and transformation. RRV
stain 17577 is also .99% identical at the DNA level to the
regions of the RRV strain H26-95 genome available for
analysis. The majority of base differences are found in the
midregion of orf 8, glycoprotein B, and predicted to en-
code both conserved and nonconserved changes in the
protein. Geographical variation in KSHV is increasingly
documented in association with different forms of KS and
KSHV infection rates and raises the possibility that se-
quence variation may relate to differences in virulence or
transmission (41–45). Interestingly, genotypic differences in
glycoprotein B of human CMV are postulated to be associ-
ated with increased virulence in BM transplant recipients
(46). This same region has not been analyzed from different
isolates of KSHV derived from AIDS-related KS, classical/
endemic KS, or LPD, and the significance of the sequence
variation in the RRV glycoprotein B gene is unknown.
RRV strain 17577 was recovered from the BM of a nat-
urally infected rhesus macaque that developed profound,
persistent angiofollicular peripheral lymphadenopathy after
experimental infection with a macrophage-tropic variant of
SIVmac239.  Subclinical multicentric involvement of lym-
phoid tissues and solid organs was found at necropsy 503 d
after SIV infection. PCR analysis of BM tissue exhibiting
lymphocytic hyperplasia revealed that RRV DNA was
present in high copy number but not in BM from normal
macaques or in macaque 18570. We speculate that the dif-
ference in viral load in the BM of animal 18570 may be
due to the lack of LPD in the BM, compared with the
florid LPD lesions observed in the BM of macaque 17577.
As a causal role for RRV in the development of these
lesions cannot be established by PCR analysis alone, we
undertook experimental inoculation studies in rhesus
macaques to determine whether RRV is just a ubiquitous
agent in nonhuman primates or a pathogen capable of in-
ducing disease manifestations in its natural host. The ab-
sence of B cell hyperplasia in the SIV- or RRV-only con-
trols and the presence of high RRV loads in hyperplastic
lymphoid tissues from SIV and RRV–coinfected macaques
indicate that B cell hyperplasia is strongly associated with
RRV. A role for RRV in B cell hyperplasia or LPDs is
consistent with the biology of most or all other gammaher-
pesviruses (KSHV, EBV, MHV-68, HVS). The index
macaque and the macaques experimentally infected with
SIVmac239 and RRV 17577 developed profound, persistent,
multicentric angiofollicular lymphadenopathy resembling
the multicentric plasma cell form of MCD either in the
absence or presence of HIV infection (47). The hypergam-
maglobulinemia in the index macaque and both experi-
mental RRV/SIV-infected macaques and the fatal immune-
mediated hemolytic anemia in one of the two experimentally
RRV/SIV-infected macaques are also clinical features that
Figure 7. Histogram of
percent CD201 cells detectable
in dissociated LNs of uninfected
controls and RRV/SIV-infected,
SIV-infected, and RRV-infected
animals. Data are mean 6 SEM;
*P , 0.05 compared with unin-
fected controls.
Table II. Concentration of Plasma Gammaglobulin in SIV and/or 
RRV Experimentally Inoculated Rhesus Macaques
Animal
no.
Before
inoculation
Weeks after SIV inoculation
16 30 42 50 70 84
17577* 784 NA NA NA NA 2,448¶
18483‡ 621 1,243 2,096 NA 2,490 NA 5,055
18570‡ 811 1,507 3,004 NA 1,795¶**
18503§ 661 585 536 NA 211¶
18540§ 789§ 607 743 NA 871 NA 1,233
19092i 494 NA NA 564
19286i 742 NA NA 648
IgG concentrations (mg/dl) were determined at different weeks after
SIV inoculation by nephelometry.
*Animal 17577 was the SIV-infected macaque with LPD and the
source of RRV strain 17577.
‡Animals experimentally inoculated with RRV and SIV.
§Animals experimentally inoculated with SIV only.
iAnimals experimentally inoculated with RRV only.
¶Samples obtained at necropsy.
**Treated with prednisolone for hemolytic anemia at 2 mg/kg begin-
ning 42 wk after SIV inoculation.
NA, samples not analyzed.837 Wong et al.
closely parallel those observed in KSHV-infected AIDS
patients and HIV-1–seronegative patients with MCD
(48–50).
Both SIV and HIV-1 induce in vivo B lymphocyte
hyperactivation, as shown by hypergammaglobulinemia,
circulating immune complexes, and sometimes elevated
levels of autoantibodies (49, 51, 52). However, the consort
of profound hypergammaglobulinemia, immune-mediated
hemolytic anemia, and progressive lymphadenopathy re-
ported here are unusual disease manifestations in SIVmac-
infected macaques, and few cases are reported (20, 39, 53,
54). The RRV infection status in these animals is not
known, as RRV was only recently identified. The absence
of hypergammaglobulinemia, immune-mediated hemolytic
anemia, and persistent angiofollicular lymphadenopathy in
our SIVmac239-only and RRV-only infection control macaques
suggest that RRV coinfection may be an important factor
in the immunopathogenesis of retrovirus-induced immu-
nodeficiency disease in macaques. This cofactor role has long
been recognized for EBV in human AIDS patients, and a
similar role is evolving for KSHV.
Despite the significant evidence of B cell hyperplasia in
the peripheral blood, LNs, and spleens of the RRV/SIV
coinfected animals, they do not appear to have overt clonal
abnormalities in their B cells, nor were we able to establish
continuously replicating primary B lymphocyte cultures
from them. This differs considerably from rhesus EBV in-
fection, where we have been able to generate continuously
replicating cultures of rhesus EBV–positive B cells in vitro
from PBMCs collected from naturally infected macaques
(our unpublished results). The evolution of clonal abnor-
malities in LPDs is complex (55), and although mono-
clonality was not evident in the LPD manifested in the
RRV/SIV-coinfected animals, minor clonal abnormalities
may be present. Recent studies suggest that differential ex-
pression of rhadinovirus cytokine and oncogene homo-
logues may play an important role in the development of B
cell hyperplasia and other abnormal cellular proliferations
(15, 48, 56, 57). Although one of the experimental RRV/
SIV-infected macaques developed fatal immune-mediated
hemolytic anemia, none of the macaques developed lym-
phoma, and continuously replicating lymphoid cells could
not be obtained from the RRV-positive, hyperplastic lym-
phoid tissues or peripheral blood. Immortalized KSHV1
cell lines have also not been established from healthy
KSHV1 carriers or KS and MCD patients, with the excep-
tion of a continuously replicating KSHV1/EBV2 cell line
obtained from the peripheral blood of an HIV-seronegative
patient with PEL who exhibited a phenotype similar to
PEL-derived cell lines (58). Thus, like KSHV, RRV may
require other transforming events or cofactors for lympho-
mas to develop.
Consistent with the association between high RRV load
and B lymphocyte hyperplasia reported here, we have re-
cently shown that healthy RRV carrier macaques harbor
RRV in their CD201 B lymphocytes in vivo (59). Recent
studies support the hypothesis that KSHV vIL-6 plays an
important role in the pathogenesis of PEL and MCD (48,
57), and a similar role for the RRV IL-6–like cytokine is
under investigation. Preliminary analysis of the RRV IL-6–
like cytokine reveals that it can functionally substitute for
cellular IL-6 in IL-6 bioassays (60). IL-6 is a cytokine with
several functions, including the ability to activate B cells
into immunoglobulin-producing cells. More importantly,
IL-6 dysregulation appears to be a factor in the develop-
ment of MCD and multiple myeloma (61, 62).
The experimental infection protocol used here, SIVmac239
infection before RRV infection, was designed to provide
RRV a replicative advantage, as most herpesviruses, e.g.,
CMV and EBV, manifest disease in immunocompromised
hosts. Moreover, serological analysis of the animals at OR-
PRC and other primate facilities reveal that .90% of im-
munocompetent animals are seropositive for RRV. De-
spite the high prevalence rates, few animals develop LPD,
implying that the host immune response is capable of con-
trolling the virus infection. What role SIVmac239 infection
plays in the disease manifestations reported here is not
clear. One possible mechanism is that SIV-induced immu-
nosuppression may be important for sustained RRV infec-
tion and replication. Some have proposed a similar cofactor
role for HIV-1 in AIDS-related KS and PEL, whereas oth-
ers believe, at least in the histogenesis of KS, that HIV-1
invokes an inflammatory response, promoting an increase
in inflammatory cytokines that sustain KS lesions (15). We
believe that RRV is likely an opportunistic infection in the
SIV-infected animals, given the absence of similar disease
manifestations in animals experimentally inoculated with
RRV or SIV alone.
Finally, in addition to providing an animal model for
some aspects of KSHV pathogenesis, coinfection studies
such as those described here should be important for AIDS
pathogenesis. Preliminary results suggest that the presence
of RRV attenuates SIV replication. The KSHV MIP-II
protein has been shown to inhibit CCR-dependent HIV
infection in vitro (63, 64). Like HIV, genetically divergent
strains of SIV utilize CCR5 and other orphan seven-trans-
membrane receptors for viral entry (65–69). With the
availability of manipulatable molecular clones, we expect
that RRV will be extremely useful as an animal model for
studying aspects of both KSHV and AIDS pathogenesis.
One significant advantage of RRV is that it can be propa-
gated and plaque titered in cultured cells, allowing molecu-
lar dissection of genes postulated to be related to pathogen-
esis. Studies are in progress to determine the role of the
vIL-6 homologue and other viral genes in KSHV-induced
disease and in this animal model of B cell hyperplasia.
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